<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20251109067926N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-06-30</date_registration>
      <primary_sponsor>Shiraz University of Medical Sciences</primary_sponsor>
      <public_title>The Effectiveness of Emotion-Focused Psychotherapy in Patients with Cardiovascular Disease</public_title>
      <acronym></acronym>
      <scientific_title>The Effectiveness of Mobile Phone–Based Microlearning Emotion-Focused Psychotherapy on Death Anxiety and Emotion Regulation among Patients Hospitalized in Cardiac Intensive Care Units</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-08-06</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>84</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/91254</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Not randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Other design features: This study is designed as a single-blind, parallel-group, quasi-experimental study with a control group, Blinding description: In this study, blinding will be implemented such that the research assistant responsible for data collection and the statistician responsible for data analysis will remain blinded to group allocation until the completion of the study.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Cardiovascular diseases.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Participants allocated to the intervention group will receive an **Emotion-Focused Therapy (EFT)** program based on the protocols developed by Greenberg et al. (62) and Simmons et al. (63), delivered using a **mobile phone–based microlearning approach**. The intervention will be administered over **three weeks** and will consist of **daily 10–20-minute educational video sessions**.The educational content will be developed based on the EFT protocol and reviewed by two faculty members with doctoral degrees in nursing and expertise in psychiatric and mental health nursing. The electronic learning materials will be prepared according to the standards of the Virtual School and E-Learning Center of Excellence of Shiraz University of Medical Sciences and will undergo instructional design, quality assurance, and technical review before implementation. The videos will be narrated and edited using Camtasia software and uploaded to a dedicated mobile application in MP4 format.Before the intervention begins, participants will receive a brief individual orientation session on using the application and accessing the microlearning content. Technical support contact information will also be provided. The application will be designed to allow sequential access to the educational sessions, بحيث participants can view each session only after completing the previous one. The application will also record participants' viewing statistics and, following completion of each video, present two short questions to assess comprehension of the session content. To minimize contamination, downloading or sharing of the educational videos will not be permitted, and the materials will be accessible only within the application.Consistent with the theoretical framework proposed by Greenberg et al., the intervention is designed to facilitate the identification, processing, expression, and regulation of emotions. To reinforce learning, each session will begin with a brief review of the previous session. Participants will be able to submit questions, share their experiences, and communicate with the research team through the application's discussion platform. In addition, brief telephone follow-up calls (1–2 minutes) will be conducted at predetermined intervals throughout the intervention period to promote adherence and reduce attrition.Outcome measures will be assessed at **baseline, immediately after completion of the intervention, and one month after the intervention** in both the intervention and control groups. The collected data will be entered into **SPSS** software for statistical analysis.**Control group:** Participants in the control group will receive **routine care only** and will not receive any components of the EFT microlearning intervention during the study period. Intervention 2: Control group: Participants in the control group will receive routine hospital care and will not receive any components of the study intervention during the trial. However, in accordance with ethical principles, the complete educational materials will be made available to participants in the control group after completion of the study and analysis of the study results.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The primary study outcomes will be made publicly available.

When:
Access will begin 6 months after publication of the study results.

To whom:
Researchers and individuals affiliated with academic institutions

Conditions:
The data will be provided for informational purposes only.

Where to obtain:
The data are available upon request via email at soror.javanmardi@yahoo.com

How to obtain:
The data are available upon request via email at soror.javanmardi@yahoo.com

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Sorur Javanmardifard</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Nursing and Midwifery, Namazi Square, Zand Boulevard, Shiraz, Iran</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>71936–13119</zip>
        <telephone>+98 71 3677 4254</telephone>
        <email>soror.javanmardi@yahoo.com</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Sorur Javanmardifard</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Nursing and Midwifery, Namazi Square, Zand Boulevard, Shiraz, Iran</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7193613119</zip>
        <telephone>+98 71 3647 4258</telephone>
        <email>soror.javanmardi@yahoo.com</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Ability to read and write at a basic level to comprehend the educational content
Ability to understand and communicate in Persian
Age between 40 and 70 years
Access to a smartphone with an active internet connection and the ability to use it
Not participating concurrently in any other similar educational programs
Willingness to participate in the study and provide written informed consent
Hospitalization in the Cardiac Intensive Care Unit (CCU)
Clinically stable condition allowing participation in brief educational activities</inclusion_criteria>
      <agemin>40 years</agemin>
      <agemax>70 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Withdrawal of consent or unwillingness to continue participation in the study at any point during the research.
Experience of a highly stressful life event, either recently or during the study period, resulting in Post-Traumatic Stress Disorder (e.g., the loss of a close family member), as determined by self-report, family report, or available health records.
Presence of moderate to severe dementia or a Mini-Mental State Examination (MMSE) score &lt; 24 (or an equivalent validated cognitive assessment), as determined by self-report, family report, or available health records.
Presence of delirium or any medical condition that precludes participation in mobile-based educational interventions.
Visual or hearing impairment that prevents participation in the interactive educational activities.
Clinical deterioration during the intervention requiring rehospitalization.
Failure to view two consecutive educational sessions provided during the intervention.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>I51</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Complications and ill-defined descriptions of heart disease</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>Behavior</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Participants allocated to the intervention group will receive an **Emotion-Focused Therapy (EFT)** program based on the protocols developed by Greenberg et al. (62) and Simmons et al. (63), delivered using a **mobile phone–based microlearning approach**. The intervention will be administered over **three weeks** and will consist of **daily 10–20-minute educational video sessions**.The educational content will be developed based on the EFT protocol and reviewed by two faculty members with doctoral degrees in nursing and expertise in psychiatric and mental health nursing. The electronic learning materials will be prepared according to the standards of the Virtual School and E-Learning Center of Excellence of Shiraz University of Medical Sciences and will undergo instructional design, quality assurance, and technical review before implementation. The videos will be narrated and edited using Camtasia software and uploaded to a dedicated mobile application in MP4 format.Before the intervention begins, participants will receive a brief individual orientation session on using the application and accessing the microlearning content. Technical support contact information will also be provided. The application will be designed to allow sequential access to the educational sessions, بحيث participants can view each session only after completing the previous one. The application will also record participants' viewing statistics and, following completion of each video, present two short questions to assess comprehension of the session content. To minimize contamination, downloading or sharing of the educational videos will not be permitted, and the materials will be accessible only within the application.Consistent with the theoretical framework proposed by Greenberg et al., the intervention is designed to facilitate the identification, processing, expression, and regulation of emotions. To reinforce learning, each session will begin with a brief review of the previous session. Participants will be able to submit questions, share their experiences, and communicate with the research team through the application's discussion platform. In addition, brief telephone follow-up calls (1–2 minutes) will be conducted at predetermined intervals throughout the intervention period to promote adherence and reduce attrition.Outcome measures will be assessed at **baseline, immediately after completion of the intervention, and one month after the intervention** in both the intervention and control groups. The collected data will be entered into **SPSS** software for statistical analysis.**Control group:** Participants in the control group will receive **routine care only** and will not receive any components of the EFT microlearning intervention during the study period.</i_keyword>
      <i_keyword>Control group: Participants in the control group will receive routine hospital care and will not receive any components of the study intervention during the trial. However, in accordance with ethical principles, the complete educational materials will be made available to participants in the control group after completion of the study and analysis of the study results</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Death Anxiety. Timepoint: At baseline (before the intervention), immediately after the intervention, and one month after the intervention. Method of measurement: Templer Death Anxiety Scale - DAS.</prim_outcome>
      <prim_outcome>Emotion Regulation. Timepoint: At baseline (before the intervention), immediately after the intervention, and one month after the intervention. Method of measurement: Emotion Regulation Questionnaire - ERQ.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shiraz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-05-23</approval_date>
        <contact_name>Research Ethics Committee of the Schools of Nursing and Midwifery and Health Management and Medical </contact_name>
        <contact_address>Vice Chancellor for Research, 7th Floor, Central Building of Shiraz University of Medical Sciences, Adjacent to the Red Crescent Society, Zand Boulevard, Shiraz, Iran. Shiraz Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
